Literature DB >> 21195399

Vitrification of mouse embryos with super-cooled air.

Mark G Larman1, David K Gardner.   

Abstract

OBJECTIVE: To develop a closed vitrification device (i.e., one that requires no direct contact with liquid nitrogen) for successful cryostorage of embryos.
DESIGN: Prospective laboratory research study.
SETTING: University-based research laboratory. ANIMAL(S): F1 mice and mouse embryos. INTERVENTION(S): Mouse embryos were vitrified using two methods and compared with nonvitrified controls. Embryos were vitrified on a device by either [1] presealing it within a straw before plunging into liquid nitrogen or [2] placing the straw into liquid nitrogen so that the air inside the straw is super-cooled before inserting the device holding the embryos. MAIN OUTCOME MEASURE(S): Survival, subsequent embryo development, and cell number were determined. Embryos were also cryopreserved for 12 months to assess long-term storage. Synchronized ETs were performed to compare viability with nonvitrified control embryos. RESULT(S): All embryos survived with both techniques. Day-4 and -5 embryo development was comparable between the two vitrification methods. Use of the presealing method resulted in a significantly lower mean cell number than the postsealing method and control. Long-term storage did not affect subsequent embryo development or cell number. The implantation and fetal development rates of embryos vitrified with super-cooled air were comparable to those for nonvitrified control embryos. CONCLUSION(S): These data demonstrate that a closed vitrification device (Rapid-i), which does not require direct liquid nitrogen contact for vitrification, is appropriate for vitrification and long-term storage of mouse embryos.
Copyright © 2011 American Society for Reproductive Medicine. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21195399     DOI: 10.1016/j.fertnstert.2010.12.003

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

1.  Survival, re-expansion and cell survival of human blastocysts following vitrification and warming using two vitrification systems.

Authors:  Ana S Lopes; Veerle Frederickx; Gunther Van Kerkhoven; Rudi Campo; Patrick Puttemans; Stephan Gordts
Journal:  J Assist Reprod Genet       Date:  2014-11-09       Impact factor: 3.412

Review 2.  Cryopreservation in ART and concerns with contamination during cryobanking.

Authors:  Mark G Larman; Shu Hashimoto; Yoshiharu Morimoto; David K Gardner
Journal:  Reprod Med Biol       Date:  2014-02-05

3.  The effect of vitrification and in vitro culture on the adenosine triphosphate content and mitochondrial distribution of mouse pre-implantation embryos.

Authors:  Mahboobeh Amoushahi; Mojdeh Salehnia; Saman HosseinKhani
Journal:  Iran Biomed J       Date:  2013

4.  Neonatal outcomes after the implantation of human embryos vitrified using a closed-system device.

Authors:  Hideyuki Iwahata; Shu Hashimoto; Masayasu Inoue; Tomoko Inoue; Keijiro Ito; Yoshiharu Nakaoka; Nao Suzuki; Yoshiharu Morimoto
Journal:  J Assist Reprod Genet       Date:  2015-01-24       Impact factor: 3.412

5.  Perinatal outcomes for transfer of blastocysts vitrified and warmed in defined solutions with recombinant human albumin: 374 babies born after 898 embryo transfers.

Authors:  Masao Murakami; Akiyoshi Egashira; Keiko Tanaka; Chizuru Mine; Hitomi Otsubo; Takeshi Kuramoto
Journal:  J Assist Reprod Genet       Date:  2014-10-19       Impact factor: 3.412

6.  A closed system supports the developmental competence of human embryos after vitrification : Closed vitrification of human embryos.

Authors:  Shu Hashimoto; Ami Amo; Satoko Hama; Kanako Ohsumi; Yoshiharu Nakaoka; Yoshiharu Morimoto
Journal:  J Assist Reprod Genet       Date:  2013-01-12       Impact factor: 3.412

7.  The new Rapid-i carrier is an effective system for human embryo vitrification at both the blastocyst and cleavage stage.

Authors:  Nina N Desai; Jeffrey M Goldberg; Cynthia Austin; Tommaso Falcone
Journal:  Reprod Biol Endocrinol       Date:  2013-05-15       Impact factor: 5.211

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.